July’s Hidden Gems Set to Soar

2024 is a Super‑Streak for the S&P 500

Yesterday’s CPI data rolled in lower than traders expected, giving markets room to breathe. In the meantime, analysts are shouting “More upside!”

Why the rally keeps getting higher

Profit spikes across Wall Street are looking sharper than ever.
Price‑inflation chatter is decreasing, nudging the index upward.
Some investors even bet the S&P 500 might hit 6,000 by year‑end.

Spotlight on two powerhouses

Two names stand out as “hot” stocks during this bullish phase. Both have a solid record of performance and major catalysts that could push them even higher.

Sezzle (SEZL)

Think of it as the new‑age fintech that’s scoring big. With a standout track record, it has shown steady growth and has the kind of financial heft that screams “price lift” when the market turns.

ADMA Biologics (ADMA)

From biotech to breakthroughs, ADMA jumped 170% YTD. The company is on track for another 15% rise as it pushes forward with its cutting‑edge pipeline.

A Quick Beat: Biotech & FinTech

Biotech boom – 170% YTD, floating potential for another 15%.
FinTech sensation – 284% YTD, poised to climb another 15%.

At the start of the year the target was 5,400 – now it’s been bumped up to 6,000, thanks to solid earnings growth and a bullish inflation backdrop.

ADMA Biologics (ADMA)

ADMA Biologics: Turning Immunology Into a Golden Ticket

ADMA Biologics (ticker ADMA) is blasting off in the battle against immune voids and nasty infections. Their latest brainchild, S. pneumonia Hyperimmune Globulin, looks like it could be the next cash‑cow for the company.

Why All the Buzz Over a 68% Revenue Spike

In 2023, ADMA’s earnings leapt 68% year‑over‑year. The boost came largely from the exploding sales of their immunoglobulin products. It’s the kind of number that makes investors grin like they’ve just found a pot of gold at the end of a rainbow.

Investor Outlook – A Cheery Forecast

Analytics guru Saqib throws his hat in the ring: “What’s great about ADMA is that it rocks a $12 stock price. With such upside potential, you can scoop up a nice pile of shares and hold tight.” He also notes that the stock has already surged by 170% this year, and he sees the market shifting another 15% further.

Bottom Line: A Fun Ride or A Serious Play?

With a 170% jump and that 68% revenue growth, ADMA offers a tantalizing mix of excitement and solid science. If you’re looking for the next payoff, this company might just be the secret sauce.

Sezzle (SEZL)

Sezzle Drives Strong Growth with Interest‑Free Installments

Fintech ace Sezzle (NASDAQ: SEZL) has once again flexed its muscles, offering shoppers the freedom to pay in installments without piling on interest. The move comes after the company leveraged a 40% jump in the popular “buy now, pay later” trend by partnering with Vallarta Supermarkets.

2023 Highlights

Revenue surged 26.9% YoY, sustaining the company’s year‑over‑year revenue climb.
Subscription income exploded by a staggering 462.8%—a headline‑grabber for any tech‑savvy news outlet.
Stock price leapt a staggering 284% since the start of the year, riding the wave of the impressive results.

Financial Highlights

Sezzle’s robust FY’23 performance showcases how the compounding effect of interest‑free financing can turn casual browsers into loyal customers. The company’s ability to bundle supermarkets into its ecosystem cues both consumers and financiers that paying later can be a win‑win.

Future Outlook

Analysts predict that the stock could keep climbing, with a potential 15% bump on the horizon. With its partnership ecosystem expanding and fresh revenue streams in the pipeline, Sezzle looks set to push the envelope further.